GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy
Abstract Background CRISPR/Cas9 system to treat human-related diseases has achieved significant results and, even if its potential application in cancer research is improving, the application of this approach in clinical practice is still a nascent technology. Main body CRISPR/Cas9 technology is not...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2024-03-01
|
| Seria: | Journal of Experimental & Clinical Cancer Research |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s13046-024-02993-1 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|